FERGUSON WELLMAN CAPITAL MANAGEMENT, INC
Position in BMY — Bristol Myers Squibb Co
CIK 869353
PORTLAND, OR
Position in BMY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$2,806,760
+$295,961 QoQ
Shares Held
46,278
-0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.89796447556074.ToString("F0")%
Shared 0.ToString("F0")%
None 1.1020355244392583.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FERGUSON WELLMAN CAPITAL MANAGEMENT, INC holds $467,957,783 across 9 Drug Manufacturers - General names. BMY ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
650,411 | $141,457,887 | |
| 2 | JNJ |
Johnson & Johnson
|
469,028 | $114,649,203 | |
| 3 | AMGN |
Amgen Inc
|
319,238 | $112,323,890 | |
| 4 | MRK |
Merck & Co., Inc.
|
385,956 | $46,426,647 | |
| 5 | NVS |
Novartis AG
|
182,356 | $27,854,879 | |
| 6 | LLY |
ELI LILLY & Co
|
21,116 | $19,421,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
46,278 | $2,806,760 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,327 | $2,136,123 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,806,760 | 46,278 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,510,799 | 46,548 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,267,628 | 50,280 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,329,405 | 50,322 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $3,150,316 | 51,653 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,980,259 | 52,692 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,877,830 | 55,621 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,379,004 | 57,284 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,233,734 | 59,630 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $3,236,737 | 63,082 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $3,917,525 | 67,497 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,337,152 | 67,821 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $4,761,250 | 68,695 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $5,712,973 | 79,402 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $3,400,305 | 47,831 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,732,344 | 48,472 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $3,551,010 | 48,624 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,101,850 | 49,749 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $4,358,462 | 73,660 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $4,934,322 | 73,845 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $4,699,397 | 74,440 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $6,960,571 | 112,213 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $7,111,928 | 117,962 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $6,303,889 | 107,209 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $6,078,446 | 109,050 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||